{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:16:48Z","timestamp":1790295408439,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.12.053","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:15:46Z","timestamp":1357172146000},"page":"1340-1348","source":"Crossref","is-referenced-by-count":183,"title":["Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial"],"prefix":"10.1016","volume":"31","author":[{"given":"Leander","family":"Grode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Ganoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Brohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"January","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.12.053_bib0005","series-title":"Global tuberculosis report 2012","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2012.12.053_bib0010","series-title":"Global tuberculosis control 2011","author":"WHO","year":"2011"},{"issue":"May (9728)","key":"10.1016\/j.vaccine.2012.12.053_bib0015","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010\u201350: cure, care, and social development","volume":"375","author":"Lonnroth","year":"2010","journal-title":"Lancet"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.12.053_bib0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1473-3099(06)70602-8","article-title":"Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review","volume":"6","author":"Steingart","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"May (9729)","key":"10.1016\/j.vaccine.2012.12.053_bib0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice","volume":"375","author":"Wallis","year":"2010","journal-title":"Lancet"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2012.12.053_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.12.053_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.12.053_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2012.12.053_bib0045","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.12.053_bib0050","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/IAI.55.7.1641-1646.1987","article-title":"Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes","volume":"55","author":"Geoffroy","year":"1987","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2012.12.053_bib0055","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2012.12.053_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394ureC::hly+ induces apoptotic vescicles for improved priming of CD4+ and CD8+ T cells","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.12.053_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1742-4658.2011.08405.x","article-title":"pH dependence of listeriolysin O aggregation and pore-forming ability","volume":"279","author":"Bavdek","year":"2012","journal-title":"FEBS J"},{"issue":"November (5493)","key":"10.1016\/j.vaccine.2012.12.053_bib0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.290.5493.992","article-title":"A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity","volume":"290","author":"Decatur","year":"2000","journal-title":"Science"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.12.053_bib0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1462-5822.2005.00631.x","article-title":"Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence","volume":"8","author":"Schnupf","year":"2006","journal-title":"Cell Microbiol"},{"issue":"September (10)","key":"10.1016\/j.vaccine.2012.12.053_bib0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.053_bib0085","unstructured":"World Medical Association. Declaration of Helsinki (revised 2008); 1964."},{"key":"10.1016\/j.vaccine.2012.12.053_bib0090","unstructured":"WHO. Expert Committee on Biological Standardization: Recommendations to assure the quality, safety and efficacy of BCG vaccines. http:\/\/www who int\/biologicals\/BCG_DB_HK_23_April_2012 pdf 2011."},{"key":"10.1016\/j.vaccine.2012.12.053_bib0095","series-title":"Mixed-effects models in S and S-PLUS","author":"Pinheiro","year":"2000"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.12.053_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.2184","article-title":"A new synthesis for antibody-mediated immunity","volume":"13","author":"Casadevall","year":"2012","journal-title":"Nat Immunol"},{"issue":"December (6062)","key":"10.1016\/j.vaccine.2012.12.053_bib0105","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.334.6062.1488","article-title":"Infectious disease. Taking a new shot at a TB vaccine","volume":"334","author":"Kupferschmidt","year":"2011","journal-title":"Science"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2012.12.053_bib0110","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2012.12.053_bib0115","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1084\/jem.20050265","article-title":"Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice","volume":"201","author":"Jung","year":"2005","journal-title":"J Exp Med"},{"issue":"December","key":"10.1016\/j.vaccine.2012.12.053_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","article-title":"Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha\/beta, IFN-gamma, and IFN-lambda in host defense","volume":"226","author":"Zhang","year":"2008","journal-title":"Immunol Rev"},{"issue":"May (6030)","key":"10.1016\/j.vaccine.2012.12.053_bib0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1126\/science.1201711","article-title":"A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection","volume":"332","author":"Kim","year":"2011","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.12.053_bib0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.12.053_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.12.053_bib0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2012.12.053_bib0145","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.12.053_bib0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri1840","article-title":"Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases","volume":"6","author":"Pantaleo","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.053_bib0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.12.053_bib0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.12.053_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2010.00991.x","article-title":"Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection","volume":"240","author":"Fillatreau","year":"2011","journal-title":"Immunol Rev"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.12.053_bib0170","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/eji.201041340","article-title":"Antibody-Fc receptor interactions in protection against intracellular pathogens","volume":"41","author":"Joller","year":"2011","journal-title":"Eur J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2012.12.053_bib0175","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.12.053_bib0180","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","article-title":"Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection","volume":"180","author":"Maglione","year":"2008","journal-title":"J Immunol"},{"issue":"June (7351)","key":"10.1016\/j.vaccine.2012.12.053_bib0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","article-title":"Detection of prokaryotic mRNA signifies microbial viability and promotes immunity","volume":"474","author":"Sander","year":"2011","journal-title":"Nature"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.12.053_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri3167","article-title":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat","volume":"12","author":"Blander","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2012.12.053_bib0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.12.053_bib0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/14760584.5.2.277","article-title":"Bacillus Calmette-Guerin vaccination and infant mortality","volume":"5","author":"Roth","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2012.12.053_bib0205","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"issue":"April","key":"10.1016\/j.vaccine.2012.12.053_bib0210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T14:28:02Z","timestamp":1595168882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12018403"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}